Lawyer profile
Aaron Gardner
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- corporate, healthcare and life sciences, intellectual property
- Office
- New York
- Active in the record
- 2023 to 2026
Deal experience
Jurisdictions
Deals
6 announced deals in the record Latham & Watkins Advises Novo Nordisk in Multi-Target Drug Discovery Partnership With Orbis Medicines Worth Up to US$1.4 Billion 21 Sept 2026
Latham & Watkins Advises LEO Pharma in Acquisition of Worldwide Rights to MC1R Agonist Dersimelagon 19 Aug 2026
Latham & Watkins Advises Sanofi on Co-Exclusive Licensing Agreement With Novavax 23 May 2024
Latham & Watkins Advises Sanofi on Collaboration With Formation Bio and OpenAI 23 May 2024
Latham & Watkins Advises Alkermes on Sale of Athlone, Ireland Facility to Novo Nordisk 3 May 2024
Latham & Watkins Advised YES, a KCK Group Ltd Portfolio Company, in IP-Backed Financing From Aon 21 Jul 2023
Deal alerts PRO
Get an email when Aaron Gardner is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile